Regulacje i polityka gospodarcza · 26/09/2025

Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Development of Zika Virus Strains for Use in Oncolytic Therapy

The National Institute of Allergy and Infectious Diseases is considering granting an exclusive patent license to Advocate Aurora Research Institute to develop Zika virus strains for use in oncolytic therapy.